创新性复方调血脂药物 new fixed dose liporegulators
调脂药物的临床应用应符合发展趋势。
In our hospital, the clinical application of lipid lowering drugs were in line with its development trends.
结果：4年中阿托伐他汀的销售始终位列第一，调脂药物的销售金额逐年上升。
Results: Among the 4 years, sales of atorvastatin were always ranked the first, and the sales sum of the drugs increased year by year.
近几年，人们发现了几种新的药物作用靶点，通过对这些新靶点的研究，有望开发出更安全有效的调脂药物。
Recently some new targets in the process of lipid metabolism were found, they may lead to the development of new drugs.
应用推荐